Capricor Therapeutics Inc (CAPR)
14.01
-0.12
(-0.85%)
USD |
NASDAQ |
Dec 24, 16:00
Capricor Therapeutics Profit Margin (Quarterly): -555.2% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 15.48% |
| ICU Medical Inc | -5.60% |
| ResMed Inc | 25.43% |
| enVVeno Medical Corp | -- |
| AIM ImmunoTech Inc | -10.57K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -143.3% |
| Return on Assets | -61.67% |
| Return on Invested Capital | -143.3% |
| Operating Margin (Quarterly) | -575.2% |
| Return on Net Operating Assets | -349.0% |